{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:01:13Z","timestamp":1778688073282,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.peptides.2024.171185","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T22:29:57Z","timestamp":1709936997000},"page":"171185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The influence of insulin-induced hypoglycemia on copeptin concentrations"],"prefix":"10.1016","volume":"176","author":[{"given":"Penelope","family":"Trimpou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Bounias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olof","family":"Ehn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Hammarsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oskar","family":"Ragnarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.peptides.2024.171185_bib1","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1210\/clinem\/dgac381","article-title":"Diagnosis and management of central diabetes insipidus in adults","volume":"107","author":"Tomkins","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.peptides.2024.171185_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.peptides.2024.171185_bib3","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1210\/jc.2010-2345","article-title":"Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome--revisiting the direct and indirect water deprivation tests","volume":"96","author":"Fenske","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.peptides.2024.171185_bib4","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1515\/cclm-2016-0559","article-title":"Comparison of ex vivo stability of copeptin and vasopressin","volume":"55","author":"Heida","year":"2017","journal-title":"Clin. Chem. Lab Med"},{"issue":"5","key":"10.1016\/j.peptides.2024.171185_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1803760","article-title":"A copeptin-based approach in the diagnosis of diabetes insipidus","volume":"379","author":"Fenske","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.peptides.2024.171185_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/cen.15018","article-title":"The diagnostic performance of copeptin in clinical practice: a prospective study","author":"Trimpou","year":"2024","journal-title":"Clin. Endocrinol. (Oxf. )"},{"issue":"10","key":"10.1016\/j.peptides.2024.171185_bib7","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1210\/jc.2007-0232","article-title":"Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects","volume":"92","author":"Szinnai","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.peptides.2024.171185_bib8","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1210\/jc.2014-4507","article-title":"Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study","volume":"100","author":"Timper","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10198","key":"10.1016\/j.peptides.2024.171185_bib9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(19)31255-3","article-title":"Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study","volume":"394","author":"Winzeler","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.peptides.2024.171185_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1530\/EJE-22-0033","article-title":"Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study","volume":"187","author":"Atila","year":"2022","journal-title":"Eur. J. Endocrinol."},{"issue":"8035","key":"10.1016\/j.peptides.2024.171185_bib11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(77)90610-9","article-title":"Plasma-arginine-vasopressin response to insulin-induced hypoglycaemia","volume":"2","author":"Baylis","year":"1977","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.peptides.2024.171185_bib12","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2006-2046","article-title":"Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay","volume":"92","author":"Katan","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.peptides.2024.171185_bib13","doi-asserted-by":"crossref","DOI":"10.1530\/EC-23-0042","article-title":"Copeptin levels increase in response to both insulin-induced hypoglycemia and arginine but not to clonidine: data from GH-stimulation tests","volume":"12","author":"Stankovic","year":"2023","journal-title":"Endocr. Connect"},{"issue":"11","key":"10.1016\/j.peptides.2024.171185_bib14","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4158\/GL-2019-0405","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care","volume":"25","author":"Yuen","year":"2019","journal-title":"Endocr. Pr."},{"issue":"4","key":"10.1016\/j.peptides.2024.171185_bib15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/cen.12608","article-title":"Gender-specific co-activation of arginine vasopressin and the hypothalamic-pituitary-adrenal axis during stress","volume":"82","author":"Kacheva","year":"2015","journal-title":"Clin. Endocrinol. (Oxf. )"},{"issue":"8","key":"10.1016\/j.peptides.2024.171185_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072876","article-title":"Concentrations of the stress hormone copeptin increase upon hypoglycaemia in patients with type 1 diabetes dependent of hypoglycaemia awareness","volume":"8","author":"Seelig","year":"2013","journal-title":"PLoS One"},{"issue":"1-2","key":"10.1016\/j.peptides.2024.171185_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-0115(00)00196-8","article-title":"Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation","volume":"96","author":"Aguilera","year":"2000","journal-title":"Regul. Pept."},{"issue":"3","key":"10.1016\/j.peptides.2024.171185_bib18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s12020-017-1366-6","article-title":"Copeptin as a marker of an altered CRH axis in pituitary disease","volume":"57","author":"Lewandowski","year":"2017","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.peptides.2024.171185_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF03350005","article-title":"The infusion of somatostatin reduces the arginine-vasopressin response to insulin-induced hypoglycemia in man","volume":"12","author":"Chiodera","year":"1989","journal-title":"J. Endocrinol. Invest"},{"issue":"2","key":"10.1016\/j.peptides.2024.171185_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1210\/jc.2017-01891","article-title":"Release and decay kinetics of copeptin vs AVP in response to osmotic alterations in healthy volunteers","volume":"103","author":"Fenske","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.peptides.2024.171185_bib21","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1210\/jc.2010-2499","article-title":"Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States","volume":"96","author":"Balanescu","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.peptides.2024.171185_bib22","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/jcem-53-5-935","article-title":"Arginine vasopressin response to insulin-induced hypoglycemia in man","volume":"53","author":"Baylis","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.peptides.2024.171185_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/frne.1994.1014","article-title":"Role of nitric oxide in the regulation of renin and vasopressin secretion","volume":"15","author":"Reid","year":"1994","journal-title":"Front Neuroendocr."},{"issue":"1","key":"10.1016\/j.peptides.2024.171185_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.1.02314","article-title":"The endocrine system in chronic nitric oxide deficiency","volume":"156","author":"Vargas","year":"2007","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.peptides.2024.171185_bib25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2265.2001.01169.x","article-title":"An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease","volume":"54","author":"Leong","year":"2001","journal-title":"Clin. Endocrinol. (Oxf. )"},{"issue":"4","key":"10.1016\/j.peptides.2024.171185_bib26","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s11102-022-01240-0","article-title":"The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: data from: glucacop, macicop, and CARGO study","volume":"25","author":"Atila","year":"2022","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.peptides.2024.171185_bib27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/cen.14880","article-title":"Arginine-stimulated copeptin in children and adolescents","volume":"98","author":"Binder","year":"2023","journal-title":"Clin. Endocrinol. (Oxf. )"},{"issue":"1","key":"10.1016\/j.peptides.2024.171185_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00431-020-03777-3","article-title":"Distribution of plasma copeptin levels and influence of obesity in children and adolescents","volume":"180","author":"Tuli","year":"2021","journal-title":"Eur. J. Pedia"},{"issue":"4","key":"10.1016\/j.peptides.2024.171185_bib29","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ijo.2012.88","article-title":"Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmo Diet and Cancer Study cardiovascular cohort","volume":"37","author":"Enhorning","year":"2013","journal-title":"Int J. Obes. (Lond. )"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019697812400038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019697812400038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:35:29Z","timestamp":1759311329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019697812400038X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":29,"alternative-id":["S019697812400038X"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2024.171185","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of insulin-induced hypoglycemia on copeptin concentrations","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2024.171185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"171185"}}